We are live on ! Find out more

156 hedge funds and large institutions have $535M invested in CareDx in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 42 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more call options, than puts

Call options by funds: $1.67M | Put options by funds: $679K

60% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 42

0.6% more ownership

Funds ownership: 108.08%108.67% (+0.6%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 168156 (-12)

19% less capital invested

Capital invested by funds: $658M → $535M (-$123M)

34% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 32

Holders
156
Holders Change
-12
Holders Change %
-7.14%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
67
Reduced
42
Closed
32
Calls
$1.67M
Puts
$679K
Net Calls
+$995K
Net Calls Change
+$2.42M
Name Holding Trade Value Shares
Change
Change in
Stake
AIM
1
ARK Investment Management
Florida
$62.1M +$7.82M +611,257 +10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$47.3M -$1.25M -97,614 -2%
State Street
3
State Street
Massachusetts
$44.6M -$11.1M -869,208 -15%
BlackRock
4
BlackRock
New York
$39.9M -$115K -9,028 -0.2%
BG
5
Bellevue Group
Switzerland
$31.4M +$3.46M +270,643 +9%
AC
6
Armistice Capital
New York
$28.7M +$33.7M +2,636,000 +527%
Sumitomo Mitsui Trust Group
7
Sumitomo Mitsui Trust Group
Japan
$25.1M +$2.4M +187,308 +7%
NAMA
8
Nikko Asset Management Americas
New York
$24.2M +$2.4M +187,308 +7%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$18.6M +$8.04M +628,715 +45%
GS
10
Gagnon Securities
New York
$18.4M +$6.63M +518,067 +35%
Millennium Management
11
Millennium Management
New York
$15.5M +$12.6M +988,259 +139%
Assenagon Asset Management
12
Assenagon Asset Management
Luxembourg
$10.6M +$12.6M +985,010 +549%
Morgan Stanley
13
Morgan Stanley
New York
$10.2M +$9.09M +710,386 +177%
Renaissance Technologies
14
Renaissance Technologies
New York
$9.39M +$1.04M +81,200 +9%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$9.29M +$441K +34,511 +4%
Goldman Sachs
16
Goldman Sachs
New York
$6.69M +$3.9M +304,617 +71%
Marshall Wace
17
Marshall Wace
United Kingdom
$5.84M +$8.18M +639,257 New
Voloridge Investment Management
18
Voloridge Investment Management
Florida
$5.69M +$1.35M +105,536 +20%
GA
19
Gagnon Advisors
New York
$4.81M +$1.12M +87,681 +20%
First Eagle Investment Management
20
First Eagle Investment Management
New York
$4.78M +$3.22M +251,692 +93%
Bank of America
21
Bank of America
North Carolina
$4.67M -$51.3K -4,013 -0.8%
CS
22
Credit Suisse
Switzerland
$4.41M -$9.58M -749,251 -61%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$4.37M -$370K -28,900 -6%
Northern Trust
24
Northern Trust
Illinois
$4.31M +$78.4K +6,132 +1%
RA
25
Royce & Associates
New York
$3.95M +$4.25M +332,400 +332%

CDNA Hedge Fund Activity: Q1 2023 in Review

156 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q1 2023, worth a combined $535M — down 19% from $658M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of CDNA and 21 opened new positions — a net loss of 11 holders — while 42 trimmed existing stakes and 67 added.

The largest buyer was Armistice Capital, adding an estimated $33.7M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $48.2M.

  • 156 institutional investors held CareDx (CDNA) as of Q1 2023, down from 168 in Q4 2022.
  • Funds reported $535M of CareDx stock for Q1 2023, down 19% quarter-over-quarter.
  • 21 funds opened new CareDx positions in Q1 2023 and 32 closed out, a net change of -11 holders.
  • The largest CareDx buyer in Q1 2023 was Armistice Capital, an estimated $33.7M added.
  • The largest CareDx seller in Q1 2023 was ArrowMark Colorado Holdings, an estimated $48.2M sold.

Based on aggregated 13F filings for Q1 2023.